Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Store lyophilized material at -20C, protected from light and moisture
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
PMC10706451 Brown B, Cohen L, Jackson R, et al
Want a logo badge or affiliate link
US$ 21.08
US$ 29.36
US$ 26.35
US$ 23.66
US$ 22.31
US$ 26.11
US$ 23.31
US$ 29.24
US$ 29.40
US$ 25.43
